Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease.
- Resource Type
- Article
- Authors
- Leung, Wing Yin; Wu, Henry H L; Woywodt, Alexander; Ponnusamy, Arvind
- Source
- Clinical Kidney Journal. Jan2024, Vol. 17 Issue 1, p1-2. 2p.
- Subject
- *RITUXIMAB
*ADULTS
*SERUM albumin
- Language
- ISSN
- 2048-8505
This article discusses the use of ultra-low dose rituximab as a treatment for relapsing adult minimal change disease (MCD). The authors present two cases where this novel approach was successful in maintaining remission. They reference two previous studies that also found favorable outcomes with ultra-low dose rituximab. The authors suggest that further research should be conducted to confirm the effectiveness of this treatment approach in relapsing MCD. [Extracted from the article]